Cargando…
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
The number of blind and low vision persons in the US is projected to increase to 5.68 million by 2020. The eye diseases causing loss of vision are life-long, chronic, and often need protracted presence of therapeutics at the disease site to keep the disease in remission. In addition, multiple pathol...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058705/ https://www.ncbi.nlm.nih.gov/pubmed/29996687 http://dx.doi.org/10.1080/10717544.2018.1486474 |